drugset / Trial / NCT00866216

Comparative Bioavailability Study of 600mg Azithromycin Monohydrate Tablets Under Fasting Conditions

NCT00866216

Phase 1 Completed 38 enrolled Sandoz
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to demonstrate the bioequivalence of Azithromycin Monohydrate 600 mg Tablets.

Timeline

Start
2003-08
Primary completion
2003-09
Completion
2003-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Azithromycin Small molecule 600 mg

Indications